Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2005
09/13/2005US6943211 polymer strands formed from at least one ethylenically unsaturated monomer(when titrated with a base form negatively charged groups) and linking the polymer strands by at least one linking group containing a hydrolytically susceptible bond
09/13/2005US6943198 Invert sugar bubbles
09/13/2005US6943192 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
09/13/2005US6943164 Pharmaceutical solutions of levosimendan
09/13/2005US6943152 DNA vaccine-PCV
09/13/2005US6943027 Contacting a nucleic acid with an organic polycation to produce a condensed nucleic acid, and then combining product with an amphiphilic cationic lipid; increased shelf life and high transfection activity
09/13/2005US6943016 incubating a mixture of astrocytes and glial cells from patient surgical resection, culturing, astrocytes joining to the culture vessel, removing the un-attached cells; purification; treating CNS trauma, neurodegenerative disorders
09/13/2005US6942877 Method for producing antibiotic composites
09/13/2005US6942874 Nucleotides consist of a purine or pyrimidine group, or derivative thereof, and an ionizable phosphate or other anionic organic molecule.
09/13/2005US6942870 For prevention of photodamage skin, for topical application
09/13/2005US6942868 Aerodynamically light particles for pulmonary drug delivery
09/13/2005US6942637 Rapid infusion system
09/13/2005US6942165 Generation of therapeutic microfoam
09/13/2005US6941948 Medicament storage and delivery devices
09/13/2005CA2469019C Pharmaceutical composition comprising a 5ht1 receptor agonist
09/13/2005CA2368650C Viral treatment
09/13/2005CA2322805C Fat emulsions for inhalational administration
09/13/2005CA2314893C Opioid agonist/antagonist combinations
09/13/2005CA2282689C Process for producing hard caramels and tablets
09/13/2005CA2235919C Non-polymeric sustained release delivery system
09/13/2005CA2193502C Sphingosomes for enhanced drug delivery
09/13/2005CA2102186C Nanoparticles having a prolonged reticulo-endothelial system capture rate
09/09/2005WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof
09/09/2005WO2005082942A2 Hydroxyethyl starch
09/09/2005WO2005082781A2 Method for preparing adjustably bioresorbable sol-gel derived sio2
09/09/2005WO2005082428A2 Plaster that reduces skin irritation
09/09/2005WO2005082420A1 Stable pharmaceutical composition comprising an ace inhibitor
09/09/2005WO2005082419A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
09/09/2005WO2005082418A1 Long-acting solid formulation comprising triptorelin acetate
09/09/2005WO2005082417A1 Directly-compressible xylitol powder
09/09/2005WO2005082416A2 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
09/09/2005WO2005082413A2 Ciclesonide and glycopyrronium combination
09/09/2005WO2005082406A1 Lactalbumin for inhibiting angiogenesis
09/09/2005WO2005082405A1 Protein drug sustained-release microparticle preparation for injection and process for producing the same
09/09/2005WO2005082393A1 Stabilized feverfew formulations
09/09/2005WO2005082383A1 A medical solution, a method for producing said medical solution and use thereof
09/09/2005WO2005082379A1 Myocardial perfusion imaging using adenosine receptor agonists
09/09/2005WO2005082369A1 Opioid delivery system
09/09/2005WO2005082360A1 Peroral preparations containing vitamin e
09/09/2005WO2005082337A2 Compositions comprising prodrugs of proton pump inhibitors
09/09/2005WO2005082336A2 Kit comprising a plaster that optionally contains an active ingredient and an agent that prevents skin irritation
09/09/2005WO2005082335A1 Ophthalmic preparation
09/09/2005WO2005082334A1 Sustained-release cream preparation
09/09/2005WO2005082333A1 Alginate viscoelastic composition, method of use and package
09/09/2005WO2005082332A2 Dissolvable film comprising an active ingredient and method of manufacture
09/09/2005WO2005082331A2 Extended release tablets of clarithromycin
09/09/2005WO2005082330A2 Co-precipitated amorphous cefditoren pivoxil and dosage forms comprising the same
09/09/2005WO2005082329A2 Process for the preparation of solid dosage forms of valsartan and hydrochlorthiazide
09/09/2005WO2005082270A1 Bolus for ruminant animals
09/09/2005WO2005082142A1 Antimicrobial medical gloves
09/09/2005WO2005082048A2 Dissolvable film and method of manufacture
09/09/2005WO2005082006A2 Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom
09/09/2005WO2005081968A2 Implant having mems flow module with movable, flow-controlling baffle
09/09/2005WO2005081825A2 Abuse resistance opioid transdermal delivery device
09/09/2005WO2005081742A2 Testosterone oral dosage formulations and associated methods
09/09/2005WO2005072700A3 Haemostatic sprays and compositions
09/09/2005WO2005072223A3 Engineered proteins, and methods of making and using
09/09/2005WO2005070391A3 Method of producing microparticles
09/09/2005WO2005051344A3 Oral solid instant-release dosage forms comprising finasteride and an anionic surfactant-methods of manufacturing thereof
09/09/2005WO2005044243A8 Transdermal analgesic systems having reduced abuse potential
09/09/2005WO2005039534A8 Lipophilic drug delivery vehicle and methods of use thereof
09/09/2005WO2005030183A3 A method for the preparation of atorvastatin calcium tablets
09/09/2005WO2005027979A3 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
09/09/2005WO2005023217A3 Granular sustained release preparation and production thereof
09/09/2005WO2005023175B1 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
09/09/2005WO2005011578A3 Preoperative treatment of post operative pain
09/09/2005WO2005009386A3 Orally dissolving films
09/09/2005WO2005007122A3 Polymer stabilization
09/09/2005WO2005000237B1 Granules containing biologically active substances
09/09/2005WO2004096998A3 Nanoparticular tumor targeting and therapy
09/09/2005WO2004093942A3 Temperature responsive systems
09/09/2005WO2004080371A3 Injectable isotonic solution of gatifloxacin pre-diluted in glucose.
09/09/2005WO2004075824A8 Pharmaceutical compositions for nasal delivery
09/09/2005WO2004064542A8 Composition for oral administration containing capsaicinoids
09/09/2005CA2691611A1 Myocardial perfusion imaging using adenosine receptor agonists
09/09/2005CA2599022A1 Opioid delivery system
09/09/2005CA2557397A1 Protein drug sustained-release microparticle preparation for injection and process for producing the same
09/09/2005CA2557323A1 Alginate viscoelastic composition, method of use and package
09/09/2005CA2557142A1 Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom
09/09/2005CA2556756A1 Compositions comprising prodrugs of proton pump inhibitors
09/09/2005CA2556492A1 Implant having mems flow module with movable, flow-controlling baffle
09/09/2005CA2555179A1 Method for preparing adjustably bioresorbable sol-gel derived sio2
09/09/2005CA2554908A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
09/09/2005CA2554870A1 Long-acting solid formulation comprising triptorelin acetate
09/09/2005CA2552346A1 Membrane scaffold proteins
09/09/2005CA2548771A1 A medical solution, a method for producing said medical solution and use thereof
09/08/2005US20050197654 Multiple section parenteral drug delivery apparatus
09/08/2005US20050197653 Filter assembly with microfabricated filter element
09/08/2005US20050197652 Drug delivery system
09/08/2005US20050197651 Vaginal ring preparation and its application
09/08/2005US20050197650 Administration apparatus for medical use
09/08/2005US20050197649 Method and apparatus for automatically modifying delivery profile of drug delivery system
09/08/2005US20050197613 Implant having MEMS flow module with movable, flow-controlling baffle
09/08/2005US20050197434 Granulate or powder for producing coating or binding agents for medicaments
09/08/2005US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same
09/08/2005US20050197388 Crystalline composition containing escitalopram
09/08/2005US20050197316 Method of enhancing drainage of lacrimal system with purinergic receptor agonists
09/08/2005US20050197308 drug delivery devices having skin piercing segments comprising solid biodegradable reservoirs containing antigens
09/08/2005US20050197304 Stimulating regeneration with naked DNA encoding bioactive agents; does not cause insertional mutagenesis, host immunogenicity or tissues targeting difficulties
09/08/2005US20050197303 Storage and pH stability; tissue inflammation and infection treatment
1 ... 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 ... 2991